Allergan to buy Kythera
June 17, 2015 at 12:04 PM EDT
Allergan
will pay a premium of approximately $2.1 billion in cash and stock to
acquire Kythera Biopharmaceuticals Inc. (Nasdaq: KYTH). The stock price jumped $13.48 to $74.20.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|